Alexandra Preisser (Hamburg)

Alexandra is involved with the following papers on occupational asthma.

Abstract Available for Phenotyping occupational asthma caused by acrylates in a multicentre cohort study. Suojalehto H, Suuronen K, Cullinan P, Lindström I, Sastre J, Walusiak-Skorupa J, Munoz X, Talini D, Klusackova P, Moore V, Merget R, Svanes C, Mason P, dell'Omo M, Moscato G, Quirce S, Hoyle J, Sherson D, Preisser A, Seed M, Rifflart C, Godet J, de Blay F, Vandenplas O, European network for the Phenotyping of Occupational Asthma (E-PHOCAS) investigators., Phenotyping occupational asthma caused by acrylates in a multicentre cohort study., J Allergy Clin Immunol Pract, 2019;:,10.1016/j.jaip.2019.10.017
Paul Cullinan, Royal Brompton Hospital, London, UK, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Olivier Vandenplas, Universite Mont-Goginne, Yvoir, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Vicky Moore, Oasys, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Joaquin Sastre, Fundacion Jimenez Diaz, Madrid, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Jennifer Hoyle, North Manchester General Hospital, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Martin Seed, Manchester University, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Rolf Merget, Bochum, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Giana Moscato, Fondazione Salvatore Maugeri, Pavia, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Xavier Munoz, Barcelona, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Santiago Quirce, Madrid, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Hille Suojalehto, Finnish Institute of Occupational Health, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Irmeli Lindstrom, Finnish Institute of Occupational Health, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Alexandra Preisser, Hamburg, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.' Cecile Svanes, University of Bergen, Norway, an author of 'Phenotyping occupational asthma caused by acrylates in a multicentre cohort study.'

Abstract Available for Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma? Vandenplas O, Godet J, Hurdubaea L, Rifflart C, Suojalehto H, Wiszniewska M, Munoz X, Sastre J, Klusackova P, Moore V, Merget R, Talini D, Svanes C, Mason P, dell'Omo M, Cullinan P, Moscato G, Quirce S, Hoyle J, Sherson D, Kauppi P, Preisser A, Meyer N, de Blay F, European network for the PHenotyping of OCcupational ASthma (E-PHOCAS) investigators., Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?, Allergy, 2018;74:261-272,https://doi.org/10.1111/all.13542
Paul Cullinan, Royal Brompton Hospital, London, UK, an author of 'Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?' Olivier Vandenplas, Universite Mont-Goginne, Yvoir, an author of 'Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?' Vicky Moore, Oasys, an author of 'Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?' Joaquin Sastre, Fundacion Jimenez Diaz, Madrid, an author of 'Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?' Jennifer Hoyle, North Manchester General Hospital, an author of 'Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?' Rolf Merget, Bochum, an author of 'Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?' Giana Moscato, Fondazione Salvatore Maugeri, Pavia, an author of 'Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?' Xavier Munoz, Barcelona, an author of 'Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?' Santiago Quirce, Madrid, an author of 'Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?' Hille Suojalehto, Finnish Institute of Occupational Health, an author of 'Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?' Alexandra Preisser, Hamburg, an author of 'Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?' Cecile Svanes, University of Bergen, Norway, an author of 'Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?'

Abstract Available for IgE Reactivity, Work Related Allergic Symptoms, Asthma Severity, and Quality of Life in Bakers with Occupational Asthma. Bittner C, Garrido MV, Harth V, Preisser AM., IgE Reactivity, Work Related Allergic Symptoms, Asthma Severity, and Quality of Life in Bakers with Occupational Asthma., Adv Exp Med Biol, 2016;:,10.1007/5584_2016_226
Alexandra Preisser, Hamburg, an author of 'IgE Reactivity, Work Related Allergic Symptoms, Asthma Severity, and Quality of Life in Bakers with Occupational Asthma.'

Abstract Available for Is specific IgE antibody analysis feasible for the diagnosis of methylenediphenyl diisocyanate-induced occupational asthma? Budnik LT, Preisser AM, Permentier H, Baur X, Is specific IgE antibody analysis feasible for the diagnosis of methylenediphenyl diisocyanate-induced occupational asthma?, Int Arch Occup Environ Health, 2013;86:417-430,
Xaver Baur, Institute of occupational medicine, Hamburg, an author of 'Is specific IgE antibody analysis feasible for the diagnosis of methylenediphenyl diisocyanate-induced occupational asthma?' Alexandra Preisser, Hamburg, an author of 'Is specific IgE antibody analysis feasible for the diagnosis of methylenediphenyl diisocyanate-induced occupational asthma?'

Full Text Available for What are the benefits of medical screening and surveillance? Wilken D, Baur X, Barbinova L, Preisser A, Meijer E, Rooyackers J, Heederik D on behalf of the ERS Task Force, What are the benefits of medical screening and surveillance?, Eur Respir Rev, 2012;21:105-111,
Dick Heederik, Institute of Risk Assessment Sciences, Utrecht, an author of 'What are the benefits of medical screening and surveillance?' Xaver Baur, Institute of occupational medicine, Hamburg, an author of 'What are the benefits of medical screening and surveillance?' Alexandra Preisser, Hamburg, an author of 'What are the benefits of medical screening and surveillance?'

Alexandra Preisser (2012)



Oasys and occupational asthma smoke logo